ZA96299B - Tricyclic benzazepine vasopressin antagonists - Google Patents

Tricyclic benzazepine vasopressin antagonists

Info

Publication number
ZA96299B
ZA96299B ZA96299A ZA96299A ZA96299B ZA 96299 B ZA96299 B ZA 96299B ZA 96299 A ZA96299 A ZA 96299A ZA 96299 A ZA96299 A ZA 96299A ZA 96299 B ZA96299 B ZA 96299B
Authority
ZA
South Africa
Prior art keywords
vasopressin antagonists
tricyclic benzazepine
benzazepine vasopressin
tricyclic
antagonists
Prior art date
Application number
ZA96299A
Other languages
English (en)
Inventor
Jay D Albright
Xuemei Du
Aranapakam M Venkatesan
Santos Efren G Delos
Marvin F Reich
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA96299B publication Critical patent/ZA96299B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA96299A 1995-01-17 1996-01-15 Tricyclic benzazepine vasopressin antagonists ZA96299B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/373,139 US5532235A (en) 1995-01-17 1995-01-17 Tricyclic benzazepine vasopressin antagonists

Publications (1)

Publication Number Publication Date
ZA96299B true ZA96299B (en) 1997-07-15

Family

ID=23471147

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96299A ZA96299B (en) 1995-01-17 1996-01-15 Tricyclic benzazepine vasopressin antagonists

Country Status (21)

Country Link
US (2) US5532235A (cs)
EP (1) EP0804440B1 (cs)
JP (1) JP4219978B2 (cs)
CN (1) CN1061658C (cs)
AR (1) AR002268A1 (cs)
AT (1) ATE381570T1 (cs)
AU (1) AU4775596A (cs)
BR (1) BR9607186B1 (cs)
CA (1) CA2210632A1 (cs)
CZ (1) CZ224897A3 (cs)
DE (1) DE69637369T2 (cs)
DK (1) DK0804440T3 (cs)
EA (1) EA000607B1 (cs)
ES (1) ES2297835T3 (cs)
HU (1) HUP9702219A3 (cs)
IL (1) IL116773A (cs)
MX (1) MX9705415A (cs)
NZ (1) NZ302159A (cs)
TW (1) TW426684B (cs)
WO (1) WO1996022295A1 (cs)
ZA (1) ZA96299B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532235A (en) * 1995-01-17 1996-07-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
WO1997017349A1 (fr) * 1995-11-09 1997-05-15 Japan Tobacco Inc. Derives heterocycliques fusionnes pentagonaux d'azepine et leur emploi pharmaceutique
JP2791430B2 (ja) 1995-11-09 1998-08-27 日本たばこ産業株式会社 縮合ヘテロ5員環アゼピン誘導体及びその医薬用途
US5880122A (en) * 1996-11-01 1999-03-09 American Home Products Corporation 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US6977254B2 (en) * 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
CN1516589A (zh) 2001-04-12 2004-07-28 用作加压素激动剂的n-联苯羰基-和n-苯基吡啶基羰基取代的二环和三环氮杂�类和二氮杂�类化合物
EP1381608B1 (en) * 2001-04-12 2007-10-10 Wyeth Cyclohexylphenyl vasopressin agonists
US7202239B2 (en) * 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7326700B2 (en) * 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7064120B2 (en) * 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
US7057046B2 (en) * 2002-05-20 2006-06-06 Bristol-Myers Squibb Company Lactam glycogen phosphorylase inhibitors and method of use
US7098235B2 (en) 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
WO2006034140A2 (en) * 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film devices for temporary or permanent occlusion of a vessel
AU2011236933A1 (en) 2010-04-05 2013-05-02 Shionogi & Co., Ltd. Cephem compound having catechol group
KR20190040140A (ko) * 2016-05-25 2019-04-17 아카나 테라퓨틱스, 엘티디. 질환의 치료를 위한 융합된 비시클릭 화합물
CN111065383A (zh) 2017-07-11 2020-04-24 沃泰克斯药物股份有限公司 用作钠通道调节剂的羧酰胺
TW202412793A (zh) * 2022-09-05 2024-04-01 大陸商上海濟煜醫藥科技有限公司 苯並氮雜卓並環化合物鹽型、晶型及其應用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766108A (en) * 1986-12-04 1988-08-23 Smith Kline Beckman Corporation Tyr-Arg-vasopressin antagonists
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
DE69009785T2 (de) * 1989-02-10 1994-11-03 Otsuka Pharma Co Ltd Carbostyrilderivate.
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
KR0167349B1 (ko) * 1989-10-20 1999-02-18 오스카 아끼히꼬 벤조헤테로 고리 화합물
US5070187A (en) * 1989-11-03 1991-12-03 Trustees Of Boston University Pharmacologically effective antagonists of arginine-vasopressin
TW199153B (cs) * 1990-08-07 1993-02-01 Dtsuka Seiyaku Kk
TW198715B (cs) * 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
EP0533240A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533243B1 (en) * 1991-09-16 1997-12-17 Merck & Co. Inc. Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives
US5204349A (en) * 1991-09-16 1993-04-20 Merck & Co., Inc. Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
EP0533242A3 (en) * 1991-09-16 1993-09-15 Merck & Co. Inc. Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
TW250481B (cs) * 1992-08-20 1995-07-01 Otsuka Pharma Co Ltd
AU5533894A (en) * 1992-11-25 1994-06-22 Yamanouchi Pharmaceutical Co., Ltd. Benzanilide derivative
WO1994014796A1 (en) * 1992-12-21 1994-07-07 Yamanouchi Pharmaceutical Co., Ltd. Novel n-(pyridylcarbonyl)benzazepine derivative and intermediate therefor
WO1994020473A1 (en) * 1993-03-11 1994-09-15 Yamanouchi Pharmaceutical Co., Ltd. Compound with vasopressin antagonism
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5532235A (en) * 1995-01-17 1996-07-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
EA000607B1 (ru) 1999-12-29
CA2210632A1 (en) 1996-07-25
BR9607186B1 (pt) 2009-01-13
AU4775596A (en) 1996-08-07
ES2297835T3 (es) 2008-05-01
EA199700111A1 (ru) 1997-12-30
JP4219978B2 (ja) 2009-02-04
EP0804440B1 (en) 2007-12-19
TW426684B (en) 2001-03-21
HUP9702219A2 (hu) 1998-07-28
MX9705415A (es) 1997-11-29
DK0804440T3 (da) 2008-03-31
DE69637369D1 (de) 2008-01-31
CN1061658C (zh) 2001-02-07
EP0804440A1 (en) 1997-11-05
NZ302159A (en) 2000-01-28
AR002268A1 (es) 1998-03-11
ATE381570T1 (de) 2008-01-15
WO1996022295A1 (en) 1996-07-25
US5719278A (en) 1998-02-17
DE69637369T2 (de) 2009-01-22
BR9607186A (pt) 1997-11-11
US5532235A (en) 1996-07-02
CZ224897A3 (cs) 1998-04-15
IL116773A0 (en) 1996-05-14
HUP9702219A3 (en) 1999-05-28
CN1181084A (zh) 1998-05-06
JPH10512867A (ja) 1998-12-08
IL116773A (en) 2000-12-06

Similar Documents

Publication Publication Date Title
HK1004132A1 (en) Tricyclic benzazepine vasopressin antagonists
ZA96303B (en) Tricyclic benzazepine vasopressin antagonists
ZA96300B (en) Tricyclic benzazepine vasopressin antagonists
IL127470A0 (en) Tricyclic benzazepine vasopressin antagonists
ZA96299B (en) Tricyclic benzazepine vasopressin antagonists
IL116777A0 (en) Tricyclic benzazepine vasopressin antagonists and their preparation
ZA96298B (en) Tricyclic benzazepine vasopressin antagonists
HK1016973A1 (en) Benzazepine derivatives with vasopressin agonistic activity
IL133788A0 (en) Tricyclic vasopressin agonists
IL144270A0 (en) Tricyclic benzodiazepines as vasopressin receptor antagonists
HU9601176D0 (en) Adhesion-receptor antagonists
AU5844896A (en) Tricyclic diazepines useful as gnrh receptor antagonists
AU3641497A (en) Tricyclic benzazepine vasopressin antagonists
HK1018057A1 (en) Tricyclic benzazepine compounds
AU3296597A (en) Tricyclic benzazepine vasopressin antagonists
IL118299A0 (en) Pharmacological use of AII-receptor antagonists
AU3296497A (en) Tricyclic benzazepine vasopressin antagonists
SI0804438T1 (sl) Triciklicni benzazepinski antagonisti vazopresina
GB9525388D0 (en) Benzazepine derivatives
GB9525365D0 (en) Benzazepine derivatives
ZA961293B (en) Muscarinic antagonists
GB9507788D0 (en) Antitumour compounds